high alert medication
Nondepolarizing neuromuscular blocking agent
CCP: Areflexia for rapid sequence intubation
Known hypersensitivity or allergy to rocuronium bromide or any component of the formulation
CCP: Areflexia for rapid sequence intubation
CCP: Areflexia for rapid sequence intubation
Produces skeletal muscle relaxation by inhibiting the activity of acetylcholine at the neuromuscular junction. Does not alter the resting electrical potential of the motor end plate, or cause muscular contraction.
Intravenous:
Skeletal muscle weakness
warning
Administration of rocuronium produces paralysis and compromises respiratory function. Rocuronium must only be used by paramedics trained and experienced in its use, and where effective oxygenation and ventilation can be maintained.
Succinylcholine: administer rocuronium only after the patient has recovered from succinylcholine-induced neuromuscular blockade
Magnesium sulfate: increases duration of neuromuscular blockade from rocuronium